The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)
Gritsone Bio Secures CEPI Funding For Its Differentiated COVID-19 Vaccine Candidate
Gritstone bio Inc (NASDAQ:GRTS) has entered into a funding agreement of up to $20.6 million with the Coalition for Epidemic Preparedness…
Gritstone Bio Enters Up To $20.6M Funding Agreement With Coalition For Epidemic Preparedness Innovations To Advance Gritstone’s CORAL COVID-19 Vaccine Program
CEPI to fund Gritstone's work on second-generation vaccines against SARS-CoV-2, the virus causing COVID-19, including a clinical trial in South Africa and manufacturing optimization
Gritstone's
Gritstone Oncology Q2 EPS $(0.33) Up From $(0.69) YoY
Gritstone Oncology (NASDAQ:GRTS) reported quarterly losses of $(0.33) per share. This is a 52.17 percent increase over losses of $(0.69) per share from the same period last year.
Cramer Advises Viewers On Palantir, SoFi And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer.
Gritstone Names Celia Economides As CFO
Gritstone bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced the appointment of Celia Economides as executive vice